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Abstract
Proteins are key components in biological systems as they mediate the signal-
ing responsible for information processing in a cell and organism. In biomedical
research, one goal is to elucidate the mechanisms of cellular signal transduc-
tion pathways to identify possible defects that cause disease. Advancements in
technologies such as mass spectrometry and flow cytometry enable the measure-
ment of multiple proteins from a system. Proteomics, or the large-scale study of
proteins of a system, thus plays an important role in biomedical research.
The analysis of all high-throughput proteomics data requires the use of advanced
computational methods. Thus, the combination of bioinformatics and proteomics
has become an important part in research of signal transduction pathways. The
main objective in this study was to develop and apply computational methods
for the preprocessing, analysis and interpretation of high-throughput proteomics
data.
The methods focused on data from tandem mass spectrometry and single cell flow
cytometry, and integration of proteomics data with gene expression microarray
data and information from various biological databases. Overall, the methods
developed and applied in this study have led to new ways of management and
preprocessing of proteomics data. Additionally, the available tools have success-
fully been used to help interpret biomedical data and to facilitate analysis of
data that would have been cumbersome to do without the use of computational
methods.

Tiivistelma¨
Proteiineilla on ta¨rkea¨ merkitys biologisissa systeemeissa¨ silla¨ ne koordinoivat
erilaisia solujen ja organismien prosesseja. Yksi biola¨a¨ketieteellisen tutkimuksen
tavoitteista on valottaa solujen viestinta¨reitteja¨ ja niiden toiminnassa tapah-
tuvia muutoksia eri sairauksien yhteydessa¨, jotta ta¨llaisia muutoksia voitaisiin
korjata. Proteomiikka on proteiinien laajamittaista tutkimista solusta, kudok-
sesta tai organismista. Proteomiikan menetelma¨t, kuten massaspektrometria
ja virtaussytometria ovat keskeisia¨ biola¨a¨ketieteellisen tutkimuksen menetelmia¨,
joilla voidaan mitata na¨ytteesta¨ samanaikaisesti useita proteiineja.
Nykyajan kehittyneet proteomiikan mittausteknologiat tuottavat suuria tulos-
aineistoja ja edellytta¨va¨t laskennallisten menetelmien ka¨ytto¨a¨ aineiston analyy-
sissa¨. Bioinformatiikan menetelma¨t ovatkin nousseet ta¨rkea¨ksi osaksi proteomiikka-
analyysia¨ ja viestinta¨reittien tutkimusta. Ta¨ma¨n tutkimuksen pa¨a¨tavoite oli
kehitta¨a¨ ja soveltaa tehokkaita laskennallisia menetelmia¨ laajamittaisten proteo-
miikka-aineistojen esika¨sittelyyn, analyysiin ja tulkintaan.
Ta¨ssa¨ tutkimuksessa kehitettiin esika¨sittelymenetelma¨ massaspektrometria-
aineistolle seka¨ automatisoitu analyysimenetelma¨ virtaussytometria-aineistolle.
Proteiinitason tietoa yhdistettiin mittauksiin geenien transkriptiotasoista ja ole-
massaolevaan biologisista tietokannoista poimittuun tietoon. Va¨ito¨skirjatyo¨ os-
oittaa, etta¨ laskennallisilla menetelmilla¨ on keskeinen merkitys proteomiikan
aineistojen hallinnassa, esika¨sittelyssa¨ ja analyysissa¨. Tutkimuksessa kehitetyt
analyysimenetelma¨t edista¨va¨t huomattavasti biola¨a¨ketieteellisen tiedon laajem-
paa hyo¨dynta¨mista¨ ja ymma¨rta¨mista¨.
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1 INTRODUCTION
1 Introduction
Proteins are one of the most important functional molecules inside a cell and are a vital
part of cell functionality, as they are responsible for mediating cellular signals and deci-
sion making processes in cells. Proteomics was the term coined by Wilkins et al. (1996)
as the large-scale study of proteins from a single organism or system. The research
of the proteome is more complicated than the study of the genome, since the protein
composition of cells differ by location and by time, while the genome is relatively stable
throughout an organism. Using the basis of the central dogma of molecular biology, it
was hypothesised that the amount of mRNA in a cell would represent the amount of
protein (Crick, 1970). However, when mRNA and protein expression was examined,
they were found to correlate poorly (Gygi et al., 1999, Dhingra et al., 2005). This led
to the realization that in order to study the proteome, it was necessary to measure the
proteins themselves, and for this, the measurement techniques were a limiting factor.
Currently the best practices for measuring multiple proteins are mass spectrometry
(MS) and flow cytometry (FCM).
Mass spectrometry is a measurement technology that can be used for measuring pro-
teins and peptides from complex mixtures (Hoffmann and Stroobant, 2001). As a
result, the proteomes of various cell types, organisms and processes have been char-
acterized like that of the yeast (de Godoy et al., 2006, Picotti et al., 2009), the fly
(Brunner et al., 2007) and human cancer cell lines (Beck et al., 2011, Nagaraj et al.,
2011). However, as an example, the exact number of proteins in the human proteome
is still unknown, giving an idea of the complexity of the problem.
Computational methods are vital for the interpretation of data produced by a mass
spectrometer. Mass spectrometry experiments generate large amounts of data, and
these used to be analyzed manually before the widespread use of computers and anal-
ysis software. The field of peptide identification is quite established (Yates et al., 1995,
Perkins et al., 1999), and although several methods for data analysis are available
(Deutsch et al., 2008), there is need for method development in data management,
preprocessing and downstream analysis (Matthiesen et al., 2011).
Flow cytometry is a method for measuring content from single cells with the use of
fluorescent antibodies, and it is often used in clinical immunology (Parslow et al., 2001).
In order to interpret flow cytometry data, the traditional method is to do manual
gating, the identification of specific cells that belong to a distinct cell population. The
requirement for laborious manual work has slowed down the use of flow cytometry for
large-scale biomedical applications, since the analysis of hundreds of samples manually
is impractical. As with mass spectrometry data analysis, there are tools available
for data analysis, but there remains a need for computational methods enabling the
analysis of flow cytometry experiments and large sample numbers (Schadt et al., 2010).
Proteomics research has become an important part in the race to understanding com-
plex diseases like cancer, that has become one of the leading causes of death, with
proportional mortality in the USA and Finland being 23%, bypassed only by cardio-
vascular diseases (35% in the USA and 41% in Finland) (WHO, 2011). It has become
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clear that the reductionist view of biology that focuses on individual proteins is not
enough to understand complex biological phenomena and that systems wide approaches
are needed (Sauer et al., 2007).
To understand these types of complex processes, it is vital to understand the signaling
that occurs inside cells, and how signals are regulated. An important regulator of cell
signaling is protein phosphorylation, a post-translational modification (PTM) where
a phosphate group is added to a serine, threonine or tyrosine amino acid residue. Ki-
nases are responsible for the addition of the phosphate, and the removal is done by
phosphatases. The phosphorylation of a protein can, for example, activate or inhibit
its activity, affect how other proteins interact with it, change its subcellular localiza-
tion or cause it to be degraded by the proteasome pathway (van Weeren et al., 1998,
Cole et al., 2003, Babior, 1999, Petersen et al., 1999, Vlach et al., 1997). Phospho-
proteomics focuses on identification and characterization of specific phosphorylation
sites of proteins. Due to the importance of phosphorylation in signal transduction,
phosphoproteomic methods have become a significant part of research on cellular sig-
naling (Krutzik et al., 2004, Mukherji, 2005, Villn et al., 2007). This type of research
is done with high-throughput measurement techniques that result in large quantities
of multivariate data, requiring sophisticated computational tools for analysis and this
thesis focuses on the development and application of such methods.
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2 Review of the literature
2.1 Methods for high-throughput proteomics
The most widely used method for high-throughput proteomics experiment is mass spec-
trometry, but other methods are available like flow cytometry, antibody microarrays,
enzyme-linked immunosorbent assays (ELISAs) and two-dimensional gel electrophore-
sis (2-DE). In 2-DE, proteins are first separated by their isoelectric point and then
by their molecular weight, and by comparing two such experiments for differing spots,
comparative proteomics can be performed (Wilkins et al., 1996, Go¨rg et al., 2004).
ELISAs are a type of biochemical assay where a specific antibody is used to detect an
antigen from a sample, with immobilization of the antigen to a solid surface, and detec-
tion of the antibody using a secondary antibody linked to an enzyme that can produce
a visible signal when substrate is added (Engvall and Perlmann, 1971, Van Weemen
and Schuurs, 1971). The identification and quantitation of specific proteins can also be
done with antibody microarrays that are spotted with specific antibodies for proteins
of interest. Their use is limited depending on the availability of suitable antibodies
but can be conveniently used for analysis of several samples, and their downstream
analysis is similar to that of spotted gene expression microarrays (Alhamdani et al.,
2009).
Flow cytometry (FCM) is a technique for counting and identifying individual particles,
like cells, from a sample. It can measure hundreds of cells every second, it is a tool for
rapid data collection. By using protein specific antibodies, flow cytometry has been
transformed into a proteomics tool, typically measuring six antibodies, depending on
the machine and antibodies used (Parslow et al., 2001). The focus of this thesis is on
computational methods for analysis of mass spectrometry and single cell flow cytometry
data, and these methods are presented here in more detail.
2.1.1 Mass spectrometry in phosphoproteomics
Mass spectrometry is a technique in analytical chemistry, where one can measure the
mass-to-charge ratio (m/z ) of a particle (Hoffmann and Stroobant, 2001, Smith, 2002).
This measurement can be used to calculate the mass of a particle and identify the
composition of a sample. The basic steps in a mass spectrometer are vaporization of
a sample, ionization by one of several methods to obtain ionized particles, separation
of particles by the analyzer based on their m/z by deflecting the particles with an
electromagnetic field, and detection of the separated ions. A simplified schematic is
illustrated in Figure 1. The detected signals are presented as mass spectra with peaks
of relative intensity at the detected m/z values.
Two methods that revolutionized the use of MS for use with biological material were
the inventions of electrospray ionization (ESI, Yamashita and Fenn (1984)) and matrix-
assisted laser desorption/ionization (MALDI, Karas et al. (1985)) in the 1980s. These
ionization methods coupled to time-of-flight (TOF) or quadropole mass filter analyzers
3
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Figure 1: A schematic representation of a simple mass spectrometer. The sample is
vaporized and ionized at the ion source from where the ions are accelerated through a
magnetic field. This field exerts forces on the ionized particles. If the particles have
the same charge, the amount of deflection is proportional to the mass of the particle.
Lighter particles are deflected more by the magnetic field than larger particles (accord-
ing to Newton’s second law of motion), and the detector collects relative intensities of
the particles. Modified from USGS (2001).
and knowledge from sequence databases made it possible to identify a protein based on
its experimental mass to its predicted mass (Henzel et al., 1993). The use of tandem
mass spectrometry (MS/MS), where multiple steps of MS are used, enabled the identi-
fication of peptide sequences. In MS/MS, first a selected m/z ratio is predefined in an
initial MS step, and particles of that specific mass are let through and are subject to a
fragmentation by, for example, collision-induced dissociation (CID). These fragments
are then passed to a second MS for analysis. The data created includes the masses of
individual peptides as well as the fragmentation spectra of these peptides, which are
then used for identification of peptide sequences, as described in later sections. In the
1990s it was already possible to measure complex mixtures of proteins from various
sources by using MS/MS and various computational algorithms comparing experimen-
tal and predicted peptide spectra. The development of new technologies continued
rapidly and different instruments like Fourier transform ion cyclotron (Marshall et al.,
1998), time-of-flight/time-of-flight quadropole-TOF (Morris et al., 1996), linear ion
trap (Quarmby and Yost, 1999), and more recently the Orbitrap orbitrap (Makarov,
2000, Hu et al., 2005) have been developed and applied to proteomics research. Ad-
ditionally new fragmentation methods like electron-transfer dissociation (ETD) (Syka
et al., 2004) and higher energy collisional dissociation (HCD) (Olsen et al., 2007) have
shown to be particularly useful for identifying proteins with post-translational modi-
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fications. Novel versions of MS technology are constantly emerging and are allowing
for more precise and sensitive measurement of sample particles (Hu et al., 2005).
Quantitative mass spectrometry
To compare two or more biological conditions, the proteins of the systems must be mea-
sured and compared. Proteins can be measured with relative and absolute methods,
using either labeling methods or label-free methods (Elliott et al., 2009). Label-free
methods typically quantify peptides either by normalizing experiments based on pep-
tide retention times and their chromatograms or by normalizing the peptide amounts
based on the number of peptides or peptides spectra identified from the MS experiment
(Griffin et al., 2010, Zhu et al., 2010). These methods have several computational soft-
ware available that compute peptide and protein amounts, like AMT (Conrads et al.,
2000) and DecyderMS (GE Healthcare) for chromatogram based quantification and
the emPAI score (Ishihama et al., 2005) and spectral counting method (Asara et al.,
2008) for quantification based only on peptide spectra. The method of selected re-
action monitoring (SRM) is also label-free, and is used for quantification of known
peptides. It uses triple quadrupole MS to first select for a specific peptide ion m/z
value, then it fragments these ions, and third it selects for a specific fragment ion of the
peptide. SRM-based experiments are able to quantify low-abundance peptides with
high accuracy, however, their use is limited to predefined sets of proteins (Lange et al.,
2008).
Two common labeling methods are iTRAQ (isobaric tag for relative and absolute
quantitation, Ross et al. (2004)) and SILAC (stable isotope labeling by amino acids
in cell culture, Ong et al. (2002)). With SILAC labeling, two samples are grown in
cell culture containing growth medium with either a “heavy” or “light” version of an
amino acid. The heavy version of an amino acid is one with a stable isotope of, for
example, carbon-13 atoms instead of the normal carbon-12. The samples grown in the
different media incorporate the heavy or light amino acid into its peptides, and these
differently weighted peptides can be differentiated in a mass spectrometer.
With the iTRAQ labeling method, each different sample is grown in a normal cell
culture medium, and the samples are labeled with the iTRAQ reagent after sample
processing (see Figure 2a). The iTRAQ labels are isobaric tags that covalently attach
to the N-terminal and sidechain amines of the peptides. Typically 4-plex or 8-plex
iTRAQ reagents are used, enabling the comparison of four or eight conditions at a
time. After labeling, the samples are mixed and run through the mass spectrometer,
and the tags can be differentiated in the spectra in a 4-plex system at m/z values 114,
115, 116 and 117 (Figure 2b).
An advantages of quantification with labeling methods is that they allow for multiplex-
ing of samples in a mass spectrometry analysis, enabling the measurement of several
experimental setups at a time. Additionally, the labels are designed to bind to all tryp-
tic peptides in a sample, allowing for the identification of novel peptides. However,
some disadvantages of the labeling methods are that they require several experimental
5
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Figure 2: Overall setup of a 4-plex iTRAQ experiment. Four different conditions can
be used when growing cells or extracting protein samples, which are then labeled with
a unique iTRAQ label (a). After labeling, these samples can be combined and run
together as one sample with LC-MS/MS. When peptides are identified, comparing the
114, 115, 116 and 117 m/z peaks shows relative amounts of that particular peptide in
each original sample (b).
steps which may introduce errors, the labeling efficiency can vary, and the labeling
reagents are relatively expensive.
Bottom-up proteomics
Bottom-up proteomics is the identification of proteins from a sample by digesting the
proteins before MS analysis. The first step in the bottom-up approach is to extract
proteins from a sample, such as whole cell extracts, subcellular fractions, proteins
secreted into cell growth media, or samples from the tissue of an organism. Proteins
are enzymatically digested into peptides of various sizes, with trypsin for example,
because peptides are more suited to measurement in a mass spectrometer (Washburn
et al., 2001, Aebersold and Mann, 2003). In a phosphoproteomics experiment, to ensure
that the low-abundance phosphoproteins can be identified from the full sample, the
phosphorylated peptides are enriched from the sample (Zhang et al., 2005, Moser and
6
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White, 2006, Thingholm et al., 2009). The most common methods for enrichment are
immobilized metal ion affinity chromatography (IMAC) (Andersson and Porath, 1986,
Michel et al., 1988), titanium dioxide chromatography (TiO2) (Pinkse et al., 2004) or
immunoprecipitation of phosphospecific proteins using antibodies (Rush et al., 2005).
The full peptide mixture cannot be placed in a mass spectrometer simultaneously, as
the instrument is not able to handle hundreds or thousands of peptides at the same time
(Hoffmann and Stroobant, 2001, Horvatovich et al., 2010, Ly and Wasinger, 2011). The
peptide sample is thus separated, typically with either gel- or chromatography-based
methods. In gel-based methods, the proteins and peptides can be separated with
2-DE or one-dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE), another gel-based method for separating peptides by size. The desired
spot is excised from the gel and then analyzed by MS.
Liquid chromatography (LC) can also be used to separate peptides based on physical
properties (Hoffmann and Stroobant, 2001). The common methods are reversed-phase
liquid chromatography, strong cation exchange chromatography, and size exclusion
chromatography (Motoyama and Yates, 2008). These separated peptide fractions are
then analyzed by MS. Bottom-up proteomics with analysis by LC-MS/MS is also called
“shotgun proteomics” (Wolters et al., 2001).
Although bottom-up proteomics is more common, the method of top-down proteomics
can also be used. In top-down proteomics, an intact protein is used as the input to
the mass spectrometer instead of peptides (Kelleher et al., 1999). The whole molecule
is ionized and subject to analysis in the MS, enabling the identification of protein
isoforms or various modifications, which are not possible with bottom-up proteomics
(Sze et al., 2002, Tran et al., 2011). This method is technically still quite challenging
(Zhou et al., 2012).
2.1.2 Flow cytometry as a tool for phosphoproteomics
The second main experimental technique covered in this thesis is flow cytometry
(FCM). This section will describe the flow cytometry technology, as well as its ap-
plications in proteomics.
In a flow cytometer, a laser beam is passed through individual cells as they flow sus-
pended in liquid (Figure 3) (Parslow et al., 2001). Light scatters due to particle size
and particle granularity, and these scatter effects are measured by detectors: forward
scatter (FSC) is measured in line with the light source and side scatter (SSC) is mea-
sured perpendicular of the light source. In a fluorescence activated cell sorter (FACS),
there are additional detectors for fluorescence signals emitted from the sample. Current
FACS equipment can typically detect up to six different fluorescense signals (Parslow
et al., 2001). Specific antibodies conjugated to a fluorophore enable the measurement
of proteins from a single cell. Typically these proteins are cell surface proteins that
help in identifying the type of cell in question. Recently, antibodies have also been used
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to measure cellular phosphoproteins, making flow cytometry an interesting proteomics
technology where one can collect vast amounts of intracellular data from a single ex-
periment (Irish et al., 2004, Lesinski et al., 2004, Mardi et al., 2001). In these types of
phosphorylation-specific experiments, the protocol includes stimulation of cells, fixing,
permeabilization and finally staining with the specific antibodies (Krutzik et al., 2004).
Data 
analysis
laser
Cell 
suspension
Single cells
Red filter
Detectors
Forward scatter light
Side scatter light
Red light
Green light
Green filter
Figure 3: Overview of a flow cytometer. The flowing single cells are hit by the laser
light, which is reflected to the various detectors. One detector is placed directly across
the laser, collecting the forward scatter signal and measuring the size of the cell. The
other detectors are placed at a 90◦ angle and the side scatter detector measures the
granularity of the cell. Additional detectors measure emitted fluorescence of a specific
wavelength and thus measure the antibody that fluorophore has been attached to.
Detectors are typically photomultiplier tubes that convert the light into an electric
signal that is transferred to a computer for data analysis.
The limitation of FCM is the use of fluorophores in detection. Each specific fluorophore
has an excitation and emission wavelength, and the overlap of the emission wavelength
causes the signal from one fluorophore to blend with the signal from a second fluo-
rophore. This phenomenon is called spectral overlap and was established in the 1970s
in two-color FACS analysis (Loken et al., 1977). The effects of spectral overlap can be
handled by a method of compensation, where the degree of overlap is first measured by
specific, controlled experiments and then corrections are made this spillover in future
measurements (Tung et al., 2004). Although the phenomenon can be corrected for, in
practice measurement is limited to six fluorescent probes in a single experiment, thus
8
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limiting the number of protein measurements one can perform.
Because of the possibilities of the technology, flow cytometry and FACS have several
applications. The traditional use is in counting cell types from within a sample based
on size, granularity, and cell surface markers. By labeling the DNA in a cell, it is pos-
sible to identify which phase of cell division a cell is in, which is another common use
of flow cytometry (Riccardi and Nicoletti, 2006, Bjo¨rklund et al., 2006). The measure-
ment of phosphorylated proteins has opened the technology for analyzing cell signaling
(Krutzik et al., 2004, Sachs et al., 2005). This thesis focuses on this application of flow
cytometry, mainly on methods for analysis of data measuring both cell surface markers
for identification of specific cell types as well as measuring cellular phoshphoproteins
relevant to signaling pathways in immunity activation (Krutzik et al., 2004, Vakkila
et al., 2008, Jalkanen et al., 2011).
2.2 Analysis of proteomics data
Bioinformatics methods for proteomics data analysis can roughly be divided into three
stages: preprocessing, analysis and interpretation. Tools for preprocessing and analysis
are quite dependent on the technology used, while data interpretation methods can
typically be used with several types of data.
The raw data from a measurement instrument should be processed before the actual
analysis of data. Typically preprocessing includes various noise filtering aspects, nor-
malization, and in the case of mass spectrometry, peptide identification is critical. Data
interpretation methods deal with data annotation and integrating new experimental
data to known biological information in biological databases. There are methods avail-
able for all aspects of analysis and an overview of these will be presented here.
2.2.1 Data preprocessing and analysis
Proteomics data from a mass spectrometer or flow cytometer needs to be preprocessed
and analyzed. In this thesis, the focus is on preprocessing of MS data and full analysis
of FCM data. An overview of the full analysis process for the two methods will be
described.
Processing of phospho-MS/MS spectra
The processing of MS data involves several steps, going from raw peak data to quan-
titated protein identifications. The raw data of an MS/MS experiment are the nu-
merous fragment ion spectra that are generated from the ionized peptides (Hoffmann
and Stroobant, 2001). Several computational methods have been developed for pro-
cessing the data, and the main methods are the database searching method and de
novo sequencing, and hybrid methods that combine elements from these two methods
(Nesvizhskii et al., 2007).
9
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The database searching method is the most common method used in proteomics re-
search (Figure 4). In this method, a peptide sequence is identified by matching an
experimental spectrum with a theoretical spectrum provided by a library of known
peptides (Nesvizhskii et al., 2007). The search space of peptides is restricted by user-
defined parameters such as mass tolerance, enzyme specificity, number of missed cleav-
age sites and allowing possible post-translational modifications.
S Q V N L Y V K
MS/MS
Protein 
sequence 
database
Compare
Ranked list of peptides
Experimental spectrum Theoretical spectrum
Figure 4: Overview of the analysis of mass spectrometry data by database searching
methods. The fragmented peptide generates a spectrum that is then compared with
spectra from a database of peptide spectra. Comparison can be done with various
algorithms. These algorithms generate ranked lists of peptides identifying the best
matches. Adapted from Nesvizhskii et al. (2007).
Two commonly used commercial database searching software programs are Mascot
(Perkins et al., 1999) and SEQUEST (Yates et al., 1995), which have different algo-
rithms for scoring the match between the experimental and theoretical spectra. Mascot
uses a probability-based Mowse algorithm (Pappin et al., 1993), based on matching
experimental and theoretical peaks, giving a final score relative to the probability
that the observed match is a random event. SEQUEST compares spectra by calcu-
lating the cross correlation between the observed and theoretical spectra (Yates et al.,
1995). A third software, ProteinPilot, uses the ParagonTMAlgorithm with a proba-
bilistic algorithm (Shilov et al., 2007). Two open source database searching methods
are X!Tandem (Craig and Beavis, 2004) and OMSSA (Geer et al., 2004).
The spectral matching method is another type of database searching method. These
methods are based on the idea that peptides are often identified repeatedly in re-
peated experiments (Craig et al., 2006). Previously identified spectra are collected in
a database library. The novel peptide is identified by correlating it with the spectra
in the library. An example of a spectral matching method is SpectraST (Lam et al.,
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2007). This method is faster than the sequence database searching, but the clear draw-
back is that it can only be used to identify already known peptides (Nesvizhskii et al.,
2007).
The method of de novo sequencing means the identification of the exact amino acid
sequence of a peptide from its spectrum (Steen and Mann, 2004, Deutsch et al., 2008).
This was traditionally the method used when manually analysing spectra. This type
of method is computationally intensive, but it is useful in cases where the amino acid
sequence may not be in any database, as in the case of unsequenced organisms or
mutated proteins.
There are always false positives occurring in the peptide identifications made by these
various peptide identification methods, and setting thresholds for the scores from the
algorithms themselves is not enough to identify a peptide to its spectrum (Nesvizhskii
et al., 2007, Deutsch et al., 2008). Recently, various statistical methods to estimate
the false discovery rate (FDR, Benjamini and Hochberg (1995)) of these identifications
have been developed. For peptide identification the main methods have been target-
decoy searching and empirical Bayes approaches (Keller et al., 2002, Elias et al., 2004,
Elias and Gygi, 2007, Choi et al., 2008). However, these FDR methods are not able to
handle all false positives. There are known to be several types of false-positive spectra
that cannot be identified using these methods, due to similarity of false positives and
their actual matched spectra (Chen et al., 2009). This means that even after using a
peptide identification program with FDR correction, the resulting identified peptides
include a significant fraction of false positives. One method for improving accuracy
of peptide assignments has been to manually validate MS/MS spectra (Koenig et al.,
2008, Nichols and White, 2009). This is, however, laborious and results may vary
depending on the experience of the person performing the validation.
Several methods for improving the quality of peptide identification have been intro-
duced, and the methods can be divided into two categories: a priori and a posteriori
methods (Koenig et al., 2008). A priori approaches analyze spectrum quality be-
fore applying peptide identification software, thereby eliminating poor quality spectra
prior to database searching (Flikka et al., 2006, Salmi et al., 2006, Renard et al., 2009).
A posteriori approaches assess quality after peptide identification, and can therefore
evaluate the quality of the spectrum in the context of a given peptide assignment. An
example of an a priori method is InsPecT, that combines local de novo sequencing
and filtering to reduce the size of the searched database, resulting in faster and more
accurate peptide identifications (Tanner et al., 2005). A priori methods are not able to
use features found from matching a spectrum to its peptide assignment, unlike with a
posteriori methods. An example of an a posteriori method is described by Keller et al.
(2002), which combines features from the raw spectra with the database search score
to identify correctly and incorrectly assigned peptides. Another a posteriori method
is DeBunker, that uses a supervised learning algorithm with features extracted from
the spectral data and peak identification information to reduce the number of false
positives in phosphorylation site identification (Lu et al., 2007). A posteriori methods
often use supervised learning to create a classifier for data analysis.
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An important part of data processing is the management of data. For the manage-
ment of MS/MS data, public data repositories like PeptideAtlas (Desiere et al., 2006),
PRIDE (Martens et al., 2005) and ProteomeCommons (Falkner et al., 2006) have been
established. Additionally, there are databases designed specifically for phosphorylation
sites and other PTMs, like Phospho.ELM (Dinkel et al., 2011) and PHOSIDA (Gnad
et al., 2011). These proteomics repositories allow for the distribution and collection of
experimental datasets and enhance scientific collaboration. For local data management
within an organization, some options have been published like ms-lims (Helsens et al.,
2010), CPAS (Myers et al., 2007) and Proteios SE (Ha¨kkinen et al., 2009). Both local
and global data management systems are important and should be implemented to
enable the comparison of data, prevent data losses and facilitating novel meta analyses
(Stephan et al., 2010, Helsens and Martens, 2012).
Classification with supervised learning methods
Supervised learning is the field of machine learning that involves the task of inferring
the class of an unclassified data point on the basis of labeled (supervised) training
data. Overviewed here are the six common classification methods that were used in
Publication I of this thesis: logistic regression, decision tree, random forest, artificial
neural network (ANN), support vector machine (SVM), and na¨ıve Bayes classifier.
In the logistic regression method, data are assumed binomially distributed and the
logistic function f(z) = 1/(1+exp−z) is used to predict the classes (Agresti, 2007). The
variable z is a measure of the contributions of the features x: z = β0 +β1x1 + ...+βnxn,
where β0 is a constant term and the β1, β2, ..., βn are regression coefficients. Logis-
tic regression methods have been used to classify cohorts of neuroblastoma patients
(De Preter et al., 2011) and nonsmall-cell lung cancer samples (Anagnostou et al.,
2011), for instance.
The decision tree algorithm makes consecutive decisions or splits on the data so
that the feature used for each split is the one that maximizes the purity of the split
(Quinlan, 1986). When constructing a tree, the data are consecutively split on each
variable and the variable that results in the most similar class labels within a group is
selected. This purity value can be calculated, for example, with the Gini impurity in
the CART algorithm (Breiman et al., 1984) or the information gain criteria in the ID3
and C4.5 algorithms (Quinlan, 1986, 1992). The leaves of a decision tree correspond
to classes. Decision tree classifiers have been found useful in biomedical science and
have been used for analyzing signal transduction pathways (Kharait et al., 2007).
The random forest classifier uses an ensemble of decision trees with out-of-bag sam-
pling where each tree is built using a bootstrap sample (Breiman, 2001). New samples
are classified with each individual decision tree classifier of the ensemble and the final
label is assigned based on a majority vote. The features used for each decision tree are
selected at random from the available features, thus as the number of trees increases,
the unimportant features will be discarded as their weight is reduced due to their small
effect to the voting. This will leave only the most informative features for classification.
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A convenient feature of the algorithm is that it has been shown to be robust to noisy
data (Breiman, 2001). The random forest is also able to report feature importance to
classification. For one feature at a time, the values are permutated and classification
is performed using the feature with permutated values together with the other (not
permutated) features. The number of votes for the correct class with perturbed values
is subtracted from the number of votes for correct class with unperturbed, original
data to obtain the average decrease in accuracy for each variable. The decrease in
accuracy of the classifier for perturbation of a feature correlates to the importance of
that feature to the overall classifier.
The artificial neural network (ANN) predictors mimic biological neural networks.
An ANN consists of neurons or nodes that are arranged to input, hidden and output
layers. The input data are processed at the input nodes by the weights the inputs
have been assigned and these are summed at the hidden nodes. The output produced
is dependent on the activation function, which is typically nonlinear, for example a
sigmoid function. The weights in the network nodes can be tuned during the learning
step of a neural network (Haykin, 1998). ANNs can model complex relationships in
data, but the resulting output is often difficult to interpret due to the algorithm’s “black
box” nature (Tu, 1996). The ANN has been the most popular supervised learning
method in biomedicine since the 1970s but its use has begun to slightly decrease
(Jensen and Bateman, 2011).
A support vector machine (SVM) is an algorithm that constructs a hyperplane or
a set of hyperplanes in a high-dimensional space, which are then used for classification
(Cortes and Vapnik, 1995). The dimension is selected to be higher than that of the
original data, making separation easier in that space. The goal is to identify a hyper-
plane that maximally separates the data, or has the largest distance to the nearest
training data point of any class. There are several successful applications of SVMs in
biomedical research and clinical diagnostics (Wang and Huang, 2011).
Na¨ıve Bayes classifier uses the Bayes’ theorem to calculate posterior probabilities for
the various classes, given the data (John and Langley, 1995). The algorithm assumes
that the features used for classification are independent of each other. The class with
the highest posterior probability is selected as the output class.
Some machine-learning methods that calculate features from the peptide sequence have
been developed. PHOSIDA is a database that contains predicted phosphorylation sites
based on experimentally measured MS spectra (Gnad et al., 2007). Another similar
method uses k-nearest neighbor and SVM techniques for predicting phosphorylation
sites (Gao et al., 2009). An SVM has also been used to create a binary classifier that
predicts whether or not SEQUEST will be able to make a correct peptide identification
(Bern et al., 2004).
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Automated analysis of flow cytometry data
As flow cytometry experiments typically measure 8 features from a cell and roughly
500,000 cells in one experiment, the resulting dataset contains at least 4 million data-
points. When such experiments are done multiple times, it is evident that computa-
tional methods are required.
The typical data processing for FCM data includes identification of various cell types
based on size, granularity or expression of specific proteins. This identification is tradi-
tionally performed manually by an expert biologist, who knows what the populations
should look like, in a process called gating. The data are visualized in a two-dimensional
space depending on the experimental parameters and gates are drawn around the data
points (Figure 5). The gates can be simple thresholds for one or two of the variables,
identifying cells as positive or negative for a protein (Figure 5a). A gate can also be a
more defined area, like a rectangle, oval or polygon circling the data points, in which
case there can be several gates defined from one visualization (Figure 5b-d). The cells
from one gate can be extracted and subpopulations can be gated by visualizing these
cells in different dimensions than the first gating dimensions.
Although gating is a standard procedure, the required manual work is very laborious,
as each gate must be placed individually. Attempts to use identical gates from one
file to another may fail because often there are shifts in the data and copied gates
would not accurately represent the same population in the shifted data. When two
separate scientists perform gating, there may be variation in the gates (Suni et al.,
2003). Additionally, when experiments can include tens to hundreds of patients or
samples and tens of experiments for one sample, manual gating is no longer practical.
The manual gating and analysis procedure involves several different software tools for
analysis, and for doing a full statistical analysis one needs to copy data from one
software to another. These types of analyses are difficult to maintain.
There are several software options when analyzing FCM data manually. As gating
is the most significant part of analysis, there are several tools that allow a user to
manually gate experiments. Commercial software like FACSDiva (BD Biosciences),
FlowJo (TreeStar, Ashland, OR) and FCS Express (DeNovo Software, Los Angeles,
CA) are popular tools, but because of the required manual work, they are often not
suitable for large-scale experimental designs. Additionally, Cytobank (Kotecha et al.,
2010) is an online tool that allows for uploading of data to a server, where experiments
can be managed, manual gating can be performed and results can be visualized and
exported, but as it does not support automatic gating methods, the same limitations
apply.
Since automated gating can significantly speed up the analysis of FCM data, several
methods have been published on automated gating strategies. Computationally, the
automatic identification of gates is a clustering problem, a branch of unsupervised
learning. Typical clustering algorithms are k-means, mixture modeling and hierarchical
clustering.
For FCM data, versions of k-means and mixture modeling have been used to automate
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Figure 5: Examples of four types of manually drawn gates. In the thresholding gate
(a), thresholds for two of the measured parameters are set to define two sectors in the
two-dimensional plot. A rectangle gate (b) gives thresholds for two dimensions of the
data. An oval gate (c) selects the cells inside an oval drawn around the specified cells,
while a polygon gate (d) can have a more unsymmetrical shape.
gating. The difficulty in automatically identifying clusters with traditional clustering
methods is that FCM data are often noisy and contains many outliers (Pyne et al.,
2009). Additionally, the populations of interest are typically not symmetrically dis-
tributed and traditional Gaussian mixture modeling is not sufficient to identify them
(Pyne et al., 2009). The available algorithms have been developed to specifically cluster
FCM data and overcome these challenges, with several available in the R Bioconductor
project (Gentleman et al., 2004).
The flowClust package (Lo et al., 2009) implements a Box-Cox transformation of the
data (Lo et al., 2008) to make the data more symmetric, with a t-mixture model to
model the FCM data. This method has been extended in flowMerge (Finak et al.,
2009), where a cluster merging algorithm is used with various information criteria
measures to merge clusters and enhance subpopulation identification. The algorithm
also automates the selection of number of clusters identified. The flowMeans method
extends flowMerge by replacing the statistical model with a faster k-means clustering
algorithm (Aghaeepour et al., 2011), where spherical k-means clusters can be merged
together to identify skewed populations. The SamSPECTRAL algorithm uses a spec-
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tral algorithm tailored to FCM data, by using a sampling method to select a represen-
tative subset of the original data for the clustering algorithm, as spectral clustering is
a computationally intensive process (Zare et al., 2010).
Computational tools that partially automate FCM data analysis have been developed.
The Broad Institute offers a module for FCM data analysis in their Gene Pattern
analysis platform (Reich et al., 2006) called FLAME (Pyne et al., 2009). The FLAME
module includes a multivariate skew-t distribution for identifying clusters from the
data. FIND (Dabdoub et al., 2011) is another tool aimed for modular analysis of FCM
data with the possibility to add additional analysis modules. The flowCore package in
Bioconductor (Hahne et al., 2009) contains the major infrastructure required for FCM
analysis that can be used with automatic gating algorithms, for example flowClust or
flowMerge. None of these tools, however, scale up to analysis of tens to hundreds of
patient files and the analyses are not maintainable.
2.2.2 Data interpretation
A systems biology understanding of data requires looking at a system from several
angles, and with different experimental methods. Genome-wide methods have become
routine as a result of this understanding (Sauer et al., 2007). Currently projects include
data from several sources, for example DNA variations, messenger RNA expression,
microRNA expression, and protein expression as in The Cancer Genome Atlas project
(TCGA, Cancer Genome Atlas Research Network (2008)) where the aim is to charac-
terize over 20 types of tumors by collecting vast quantities of molecular and clinical
data for analysis.
Already ten years ago the yeast galactose-utilization pathway was studied by Ideker
et al. (2001), by measuring gene and protein expression and combining this knowledge
with database information and relating this information to critical parts in the path-
way. Since then, the importance of integrating genomics and functional data, and using
a systems biology approach has been recognized (Ge et al., 2003, Reif et al., 2004, Ag-
garwal and Lee, 2003, Vidal et al., 2011). Integration often also includes metabolomics
data, measurements of the various metabolites of a system (Cheema et al., 2011).
It was realized several years ago that one could not estimate protein abundance from
gene expression studies and that there were no clear correlations between these types
of data (Gygi et al., 1999, Waters et al., 2006). The technical sources of error, such as
problems with mRNA hybridization errors or the dynamic range of proteomics meth-
ods, could not explain the lack of the correlation. The dynamics surrounding these
biological phenomena make the identification of correlations difficult, as mRNA and
protein molecules have differing stabilities and thus different half-lives and produc-
tion rates (Komili and Silver, 2008). A recent study was able to analyze the mRNA
and protein expression of mammalian cells with well-controlled parameters and found
higher correlations between mRNA and protein levels than before, though the respec-
tive half-lives did not correlate (Schwanhausser et al., 2011). There are also recent
studies developing novel computational methods utilizing correlations between data
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from mRNA and protein levels (Bhardwaj and Lu, 2005, Tan et al., 2009).
At the heart of data integration is data annotation. Proper annotation of genes and
proteins is necessary for systems biology approaches and enabling the use of database
information. It is a common issue that different platforms use different annotation
methods, and combining datasets can be quite cumbersome and needs to be addressed
in each analysis (Dai et al., 2005). When integrating data, as in Publication III, it is
important to keep these issues in mind and re-annotate data if necessary.
Once the annotations to genes and proteins have been considered, this information can
be integrated with knowledge from available databases that include various types of
additional information. The Gene Ontology (GO) database (Ashburner et al., 2000)
has been created as a tool for defining a controlled vocabulary for all the roles genes and
proteins have in a biological system. The three separate ontologies (biological process,
cellular component and molecular function) give hierarchical information that can be
used, for example, for identifying enriched gene ontology terms. Gene set enrichment
analysis (GSEA) is a method developed for the interpretation of gene expression data.
It uses predefined gene sets, such as GO categories, to identify gene sets that are
correlated with the phenotype in question (Subramanian et al., 2005)
Another biological database commonly used for data interpretation is the Kyoto En-
cyclopedia of Genes and Genomes (KEGG) database (Kanehisa et al., 2010). KEGG
is a manually curated database that integrates genomic, chemical and functional in-
formation thereby linking various genes and proteins together into pathways. These
pathways can represent signal transduction pathways, metabolic pathways, or cellular
processes like cell cycle. Pathway databases are an additional source of information
that can be used to interpret high-throughput information, for example, identifying
which pathways are found to be enriched in the data.
Using pathway information from databases, several methods have been developed for
pathway analysis. DAVID (Dennis et al., 2003), KOBAS (Wu et al., 2006), SPIA
(Tarca et al., 2009) and Moksiskaan (Laakso and Hautaniemi, 2010) are all examples of
such pathway analysis methods. Of these, SPIA (Signaling Pathway Impact Analysis)
integrates traditional GSEA based on KEGG pathways with a perturbation factor for
each pathway based on how measured expression changes across the topology of that
pathway. The SPIA pathway analysis method was used in Publication III to identify
perturbed pathways from both proteomics and transcriptomics data.
Computational framework for data analysis
Computational tools for integrated data analysis are a necessity when integrating and
analyzing multiple datasets and database information (Almeida, 2010). Computa-
tional frameworks that enable the analysis with various computational tools, like Tav-
erna (Hull et al., 2006), GenePattern (Reich et al., 2006) and Anduril (Ovaska et al.,
2010). The Taverna software enables the use of various web services in an integrated
framework. The GenePattern software package has tools for analysis of various data
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types, as well as a web-based interface where the analysis pipeline can be created in a
straightforward way.
The Anduril framework, used in this thesis, is a workflow tool that allows the analysis
of data using components that are individual software packages that can be written
in several languages like Java, R, MATLAB or Python (Ovaska et al., 2010). There
are hundreds of components already available in the core bundle of Anduril and new
components are regularly made. Tools for a specific task can be organized in bun-
dles, which can be distributed separately from the Anduril core. The use of Anduril
components reduces the amount of code needed in an analysis, since components can
be reused. Also the abstraction level of the network level code is higher than for any
individual programming language, making the use of workflows intuitive and faster to
use.
Computational methods for analysis of biomedical data are often implemented in var-
ious programming languages with various interfaces for data import and export. This
can make novel software difficult to obtain, install and utilize. Importing these vari-
ous types of methods into the Anduril framework is possible as Anduril components
can be written in one of many common programming languages. This kind of flexible
framework thus allows for the use of novel algorithms for various types of data analysis.
In the case of existing flow cytometry data analysis methods, importing these meth-
ods from various sources can enable thorough comparison of clustering algorithms and
data analysis can be executed with the method of highest quality. Also, when these
methods have once been imported as components into the Anduril framework, it is
straightforward for others to use them as well, and to utilize the other components
already available in the Anduril analysis bundles.
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3 Aims of the study
The research conducted in this study aimed at systematizing the analysis of proteomics
data, by focusing on all phases of data analysis: preprocessing, analysis and interpre-
tation. The main focus area was in quantitative proteomics and specifically in mass
spectrometry and flow cytometry data.
The specific aims of the study were to:
1. Develop a classification method for preprocessing and validating phospho-MS/MS
data and improve data management.
2. Develop a data analysis pipeline for analysis of large-scale phospho-flow cytome-
try experiments from clinical patient samples, including an interactive interface
for gating and utilizing parallel programming capabilities.
3. Enable interpretation of data in a study of macrophage response to β-glucans
by performing statistical analysis on proteomics and transcriptomics data and
integration of the data types together and with information from biological
databases.
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4 Materials and methods
4.1 Data
An overview of the data used is presented here, and detailed information can be found
in the individual publications.
4.1.1 Mass spectrometry data
Mass spectrometry was the main experimental technology used in Publications I and
III. In all cases 4plex-iTRAQ labeling (Applied Biosystems) was used with four differ-
ent isobaric tags for four different cell types or stimulations.
For the data in Publication I, there were 11 phosphotyrosine datasets used and one
phosphoserine/-threonine dataset. Of the phosphotyrosine datasets, four were lung
cancer cell line lysates (H529, H2073, H2122, and Calu-6) (ATCC), four from MCF7
breast cancer cells overexpressing HER2 and/or with tamoxifen resistance induced by
long-term low-dose exposure, and three were breast cancer cell lines T47D, A549, and
Met2a (with or without c-Met overexpression). The phosphoserine/threonine data was
from experiments with rat liver tissue as described by Moser and White (2006).
For the data in Publication III, macrophages were differentiated from monocytes de-
rived from healthy donor peripheral blood mononuclear cells (Pirhonen et al., 1999).
One of four stimulations was used: unstimulated, lipopolysaccharide (LPS), glucan
from baker’s yeast (GBY) or curdlan stimulation. The cell culture media of these
cells was collected and labeled with 4-plex iTRAQ reagents. The labeled peptides
were fractionated and each fraction was analyzed twice with nano-LC-ESI-MS/MS
with Ultimate 3000 nano-LC (Dionex) and QSTAR Elite hybrid quadrupole time-of-
flight mass spectrometer (Applied Biosystems / MDS Sciex) with nano-ESI ionization
as previously described (Lietzen 2011). Proteins were identified and quantified with
ProteinPilot 2.0.1 software (Applied Biosystems) and a search against a decoy database
was used for false discovery rate estimation. ProteinPilot identification and quantita-
tion results were manually checked.
4.1.2 Flow cytometry data
Data used for developing the FlowAnd pipeline were from a previously published study
by Jalkanen et al. (2011) with data from 37 patients with chronic myeloid leukemia
(CML). Blood samples were taken from four different sample groups: healthy con-
trol subjects (n = 7), CML patients at diagnosis (n = 10), after imatinib treatment
(n = 10) and after dasatinib treatment (n = 10). For examining the signaling dif-
ferences between the samples, the cells were stimulated ex vivo with a control PBS-
stimulation (phosphate buffered saline) or one of three cytokine cocktails, reflecting
different pathways of immune system regulation. After stimulation, cells were lysed,
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fixed and stained with different combinations of fluorescent antibodies for flow cytom-
etry analysis. Each antibody panel contained six antibodies, of which details can be
found in Publication II and Jalkanen et al. (2011). The cells were analyzed with a
6-color flow cytometer (FACS CantoI or CantoII, BD Biosciences).
4.1.3 Transcriptomics data
In Publication III, in addition to identifying the secreted proteins from macrophages
after stimulation, the transcriptional profiles for these secreting cells were measured.
Total RNA from the stimulated macrophages was extracted and measured using an
Agilent Whole Human Genome 4x44K 1-Color Array (Agilent Technologies). Three
biological replicate experiments of each stimulation were done.
4.2 Preprocessing of mass spectrometry peptide identifi-
cation data
Data processing
The raw MS/MS-data was run with Mascot 2.1 (Matrix Science) to identify phos-
phorylated peptides. For the original 12 datasets, the peptides were validated by two
experienced LC-MS/MS users and these were checked by a third user to ensure that
the criteria used for validation were consistent. In total, we used 2,662 manually cu-
rated MS/MS spectra. Validation was either labeled as “correct” or “incorrect”, and
an “incorrect” status was given if either the peptide sequence or the post-translational
modification (PTM) was incorrectly placed. The raw spectral data, peptide informa-
tion and validation status were input into a MySQL database using the phoMSVal
tool developed in Publication I. Only peptides that had phosphorylation sites were
included in the analysis, as these had been enriched for in the experimental protocol
and this is what we were specifically interested in.
The phoMSVal library is written in Python. It is a set of scripts with which it is
possible to upload data to a MySQL database for data management, including the
peak data, peptide assignments and quantitation information. It can also validate
peptide assignments using a specified classifier by building the classfier with data
available in the database and using it to classify a specified dataset in the database.
The classifiers used were logistic regression, decision tree, random forest, artificial
neural network (ANN), and na¨ıve Bayes classifier. Classification methods were from
the Weka machine learning workbench (Witten and Frank, 2005). To facilitate use
by biologists, who are not necessarily acquainted with programming, there is also a
graphical interface available for classifying spectra in the database.
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Extraction of features for classification
We selected 17 features for classifying the spectra, of these 16 were previously described
and one novel feature. Several features were related to standard spectrum statistics
like mean peak intensity, standard deviation, total intensity, number of peaks, number
of very low peaks, intensity of most intense peak, m/z value of most intense peak and
maximum m/z value. The intensity balance of a spectrum was introduced by Bern
et al. (2004), relating the intensity of peaks along the m/z scale. The Mascot score
itself was used as a feature, which is calculated by the algorithm and expresses how well
the spectrum matches the assigned peptide. Some of the features were based on the
labels of peak identifications: averages of intensities of b-ions, y-ions and unidentified
peaks, the number of fragment ion neutral losses, average intensity of fragment ion
neutral losses, and the percent of unidentified peak intensities explained by neutral
losses.
The novel feature was the percent of unidentified high intensity peaks, which was based
on the observation that correctly assigned spectra typically had most or all of the high
intensity peaks matched to a fragment. If spectra had several high-intensity peaks that
had not been assigned, it was typically a sign that the spectrum had been assigned
incorrectly.
4.3 Analysis of flow cytometry data from CML patients
The FlowAnd tools for analysis of flow cytometry data were implemented in the freely
available Anduril framework (Ovaska et al., 2010). There are five main modules in
the FlowAnd library for the analysis of flow cytometry data: data import, prepro-
cessing, gating, population identification and statistical analysis (Figure 6). The first
step is data import, which is done using the flowCore package (Hahne et al., 2009)
in Bioconductor. Preprocessing includes tools for compensation and transformation
of both fluorescent and scatter channels. For gating, three clustering methods were
imported into the framework as their own components: SamSPECTRAL (Zare et al.,
2010), a spectral clustering method with sampling; flowMeans (Aghaeepour et al.,
2011), k-means clustering modified for FCM data; and mixture modeling with t-skew
distribution as in the FLAME analysis pipeline (Pyne et al., 2009). Population identi-
fication includes a graphical module where the user can visually inspect the clustering
results and identify which cluster belongs to which population. Statistical analysis
and visualization of the results can be done with various Anduril components, such as
heatmaps and statistical testing.
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Figure 6: An overview of the FlowAnd analysis pipeline. Data are imported, prepro-
cessed, gated with one of three algorithms, and populations are identified. If correct
populations are not identified or if subpopulations are needed, gating can be performed
again. Finally, the population results can be analyzed by various statistical tools, for
example statistical tests or visualization with heatmaps.
4.4 Analysis and interpretation of proteomics and tran-
scriptomics data in β-glucan induced macrophages
To obtain a list of differentially secreted proteins from differently stimulated macrophages,
the two replicate MS/MS experiments were combined. For proteins identified with
both replicate experiments, the relative quantitation was averaged if the fold change
values between the replicates was under 2.0. If the fold change value in one replicate
was under 4.0, the fold change difference was under 3.0 and both quantifications had
p-values reported by ProteinPilot under 0.05, signifying that there was statistically
significant evidence that the peptide identification was correct, the fold change values
were averaged. Lastly, if both fold change values were over 4.0 and both had p-values
under 0.05, the values were averaged. These criteria were used so that we could use
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the combined information of the replicate experiments while losing as little information
as possible. Protein quantitation from an individual experiment was included if the
quantitation had a p-value of under 0.05.
For the replicates of microarray expression data, the Agilent probes were re-annotated
to the Ensembl genomic database (v. 60), as incorrect annotation is a known issue
(Dai et al., 2005). The fold change for a gene was then calculated for each stimulation
vs. the control using the median of the three replicates.
Each gene and protein was annotated to their Gene Ontology terms from Ensembl. GO
enrichment was calculated with Fisher’s Exact Test (Agresti, 1992) using a genome-
wide reference set for human genes as the reference. The pathway enrichment analysis
was performed with SPIA (Tarca et al., 2009), which uses the KEGG pathway database
(Kanehisa et al., 2010), excluding human disease pathways. Secretory proteins were
predicted using SignalP (Petersen et al., 2011) service.
All data analyses were performed with the Anduril framework (Ovaska et al., 2010).
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5 Results and Discussion
5.1 PhoMSVal preprocessing improves phospho-MS/MS
data quality (I)
Preprocessing of phospho-MS/MS has not yet been resolved to satisfaction. Validation
of peptide assignments is needed to achieve accurate data, and the manual time spent
on validation led us to develop an automated method for this task. Also, a system for
managing and storing phospho-MS/MS data was needed, as the data from individual
experiments was typically unorganized. For the preprocessing of phosphopeptides, we
developed a method, phoMSVal, that performs classification on new phospho-MS/MS
datasets using a classifier with features from already validated spectra and their pep-
tide assignments. Additionally, phoMSVal takes care of storing the new data into a
database, from where it can be used for the classification of future datasets.
We collected data from 12 different phosphoproteomics experiments performed with
LC-MS/MS. Eleven of the datasets were from phosphotyrosine experiments and an
independent validation dataset from a phosphoserine and -threonine experiment was
also used. To ensure we were building the classifier with proper data, all data were
manually curated by three experts in comparison to the Mascot peptide identification.
Manual validation was based on whether the identification of the phosphopeptide was
correct or incorrect. A total of 2,662 spectra were validated and used in this study.
We selected 17 features from the spectra that were used to classify each as a correctly
identified peptide or incorrectly identified peptide. We calculated the correlations
between the features (I, Figure 3), removing features that correlated over 95%. The
number of peaks and number of very low peaks were found to be correlated, and the
number of peaks was selected for removal. There was a group of three features that also
had a high correlation: average peak intensity, average intensity of unidentified high
intensity peaks, and standard deviation of peak intensities. Of these three features,
only standard deviation was retained. Lastly, maximum intensity was also removed,
due to correlation with standard deviation and total intensity features. This left a
total of 13 features for classification.
Previously Lu et al. (2007) and Bern et al. (2004) had used SVM-classifiers for pre-
diction phosphorylation sites and predicting the quality of a SEQUEST result for a
given spectrum. We decided to test and compare several classification algorithms and
identify which one would suit this case the best using the Weka machine learning
workbench (Witten and Frank, 2005). Five different classification methods were used
(logistic regression, decision tree, random forest, artificial neural network and na¨ıve
Bayes classifier) with the thirteen features remaining after the correlation analysis.
The analysis method and software, phoMSVal, includes a data import mode, spectral
peak identification mode, feature extraction mode and classification mode (I, Figure 1).
Data are stored in a MySQL database, from where it is exported during classification
for feature calculation. The user can input the spectral information in the form of
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.mgf files and the peptide identification information as text files. When running an
analysis, the user can select which of the five classifiers to use. The tools and data are
freely available online at http://csbi.ltdk.helsinki.fi/phomsval.
For the comparison of classifiers, we first used cross-validation with all phosphotyrosine
datasets, after which we also validated the classifiers with a separate phosphoserine
and -threonine dataset. As metrics for the comparison, we generated receiver operating
characteristic (ROC) curves and calculated area under the ROC curve (AUC) values for
each of the classifiers. The ROC curve is a plot of sensitivity versus (1− specificity)
of a binary classifier, visualizing the fraction of true positives versus the fraction of false
positives, and the AUC value gives the probability that a randomly chosen positive
instance will be ranked higher than a randomly chosen negative one (Fawcett, 2006).
We also calculated the positive predictive value (PPV) for each classifier, which was
used as a secondary metric. The PPV is the fraction of true positives over all positively
classified events or
true positives
true positives + false positives
.
The PPV was selected as a secondary metric, because it expresses how well a classi-
fier can minimize the number of false positives while maximizing the number of true
positives. When using an automatic method, it is beneficial to be able to accept all
instances that are classified as “correct” while including as few false positives as pos-
sible. Then the “incorrect” cases can be checked manually, thus reducing the manual
work.
When comparing the five classifiers, we found that all four classifiers except the de-
cision tree performed better than Mascot alone (I, Figure 4), with the random forest
algorithm performing the best with the cross-validation dataset (AUC of 0.977) and
logistic regression best for the independent validation (AUC of 0.920). The fact that
the classifiers performed so well on the independent validation set showed nicely that
the features were not specific to phosphotyrosine data classification.
To analyze the features, we used the feature of the random forest algorithm to calculate
the relevance of the different features. With this analysis we found that the Mascot
score and percent of unidentified peaks, our novel feature, were the most important
features (I, Table 2).
To dig deeper into the relevance of the features, we ran each of the classifiers with all
possible combinations of the 13 features, resulting in 8,191 (213−1) different classifiers.
These classifiers were constructed with cross validation and tested with the indepen-
dent validation set. The AUC values with optimized feature sets were improved for
all classifier types, as well as for the independent validation datasets. The features
that were found in all optimal feature sets for the classifiers were the Mascot score
and percentage of unidentified peaks. This was similar to the results of the feature
importance analysis done with the random forest algorithm, which selected the same
two features as important.
As for the optimal classifiers, the one that performed the best with the cross-validation
26
5 RESULTS AND DISCUSSION
setting was the random forest classifier, using 10 of the features (I, Table 3). For the
independent validation set, the best was the na¨ıve Bayes classifier using only three fea-
tures. The classifier was able to reduce false positive identifications of phosphorylation
sites of peptides by 76% while retaining 97% of true positives.
Multiply phosphorylated peptides are more difficult for standard algorithms to identify
(Lees et al., 1991, Sørensen et al., 1995, Steen et al., 2006). In these datasets, there
were 52 spectra with multiple phosphorylation sites. Mascot incorrectly assigned 21
spectra while with phoMSVal there were only 4 false positives, thus reducing false
positives from 40% to 18% while retaining 58% of true positives.
It could be seen that the phoMSVal analysis method was able to mimic the task of
manual validation done my experienced LC-MS/MS users. The laborious task of man-
ual validation can be assisted with the use of this method, since with a well performing
classifier the user will only need to manually check spectra that are classified as “incor-
rect” and “correct” spectra can be automatically accepted. Additionally, phoMSVal
can be used with peptide identification software other than Mascot, like SEQUEST,
OMSSA and X!Tandem, because peptide identification import is a flexible format and
features used for classification are calculated from the spectra directly. PhoMSVal is a
tool that can improve the quality of high-throughput phosphoproteomics datasets by
decreasing false-positive identifications.
5.2 Data analysis framework for flow cytometry experi-
ments from CML patients (II)
Chronic myeloid leukemia is a cancer of the white blood cells, typically arising from
the presence of a translocation between chromosomes 9 and 22 called the Philadelphia
chromosome (Ph). The presence of this translocation generates a fusion protein BCR-
ABL1, that is disregulated and constitutively active, allowing cells with this mutation
to proliferate without the need for cytokines (Faderl et al., 1999). This is the main
reason for cells transforming into cancerous cells. CML can be treated largely with
tyrosine kinase inhibitors (TKIs) that specifically inhibit the phosphorylation of a
tyrosine residue of a protein, not inhibiting serine or theronine phosphorylation sites
(Hehlmann et al., 2007). The first TKI for CML patients, imatinib mesylate, has
been a revolutionary drug as it has significantly increased the rate of remission of the
disease in patients (Hughes et al., 2003). However, all patients cannot tolerate imatinib
and resistance may develop over time (Hehlmann et al., 2007), and for these patients
second generation TKIs have already been developed, such as dasatinib and nilotinib
(Hantschel et al., 2008), for which research is still ongoing (Jalkanen et al., 2012).
Flow cytometry has been shown to be a sensitive assay for measuring specific phos-
phoproteins from clinical patient samples (Vakkila et al., 2008). The analysis of these
large FCM datasets is a laborious task, and downstream analysis is impractical with-
out proper computational tools. Although some tools like FLAME and Cytobank
were available as full data analysis frameworks, they were not suitable for the analysis
of large experimental datasets from patient material. Using the Anduril framework
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(Ovaska et al., 2010), we developed a library for analysing data from flow cytome-
try experiments called FlowAnd, which enables the analysis of data from dozens to
hundreds of patients without extensive manual work. A general overview of the steps
required for analysis and how they are implemented in FlowAnd, is shown in Figure
6. The method was developed and tested on patient data from CML patients. The
method, data and user guide are freely available at http://csbi.ltdk.helsinki.fi/flowand.
5.2.1 Full analysis of single patient data for comparison of gating
algorithms
To demonstrate how an analysis with FlowAnd is executed, we decided to replicate a
manual analysis from data by Jalkanen et al. (2011). This dataset from one patient
sample included 10 FCM files with measurements from four panels of antibodies and
three different stimulations and a control stimulation. As we did not know how the var-
ious clustering algorithms would perform, we decided to perform the analysis pipeline
with all three versions in parallel. To replicate a manual analysis, the endpoint of the
analysis was set to be the identification of the monocyte, lymphocyte and granulocyte
populations.
The first step in an analysis is to filter the data and identify cells from debris. This
sample data were generated from permeabilized cells, which contain large quantities of
debris. Clustering unfiltered data can hinder the identification of populations of inter-
est, thus requiring a filtering step before clustering for population identification. The
data were clustered on the basis of five variables, the two scatter channels and CD45,
CD4 and CD25 or CD3, depending on which panel had been measured. The debris
filtering was based on how the filtering is done manually, by removing the clusters that
had lower median values for forward scatter, side scatter and CD45 than the average
cluster median values (comparing Figure 7a and 7b). The raw data contained roughly
340,000 cells in each file, and after filtering out debris they were reduced to around
70,000 cells, a reduction of almost 80%. The data were visually inspected to assure
that no relevant data were removed.
The debris-free data were clustered with the assigned algorithm, now with the goal of
achieving biologically relevant clusters for the identification of the three populations
of interest. The same five variables were used for clustering as with the clustering for
filtering. The clusters were visualized and assigned to populations.
The three clustering algorithms were found to give somewhat different results. The
flowMeans and SamSPECTRAL algorithms gave good results when compared to the
biologically relevant clusters identified by manual gating (a representative image of
clustering shown in Figure 7c). The mixture modeling algorithm resulted in too many
clusters (Figure 7d) which were not able to identify biologically relevant clusters.
As an estimate for how the automatically clustered populations compared to the man-
ually gated populations, the correlations of the median values of the populations were
calculated. SamSPECTRAL had the highest correlation of 0.99, and flowMeans and
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Figure 7: An example of how FCM data is processed with FlowAnd. In (a) the
raw data from one experiment is plotted in the SSC and CD45 dimensions, which is
typically done when manually gating data. The next step is to remove debris, which
is done by clustering data and removing the clusters that have low median values in
both dimensions. The figure in (b) visualizes the removed clusters and data in gray
coloring. The final step is to cluster the data for identification of biologically relevant
clusters, of which a well performing example is shown in (c). An example of how the
mixture modeling algorithm worked on the data is seen in (d).
FLAME had correlations of 0.69 and 0.42, respectively, demonstrating a clear differ-
ence between the methods.
For more detail, we compared the specific classification of individual cells. For each
cell and clustering algorithm, we identified whether it had been classified to the same
population with manual and automatic gating, and with this information calculated
the F-scores for each algorithm. The F-score is calculated as
F = 2 · precision · recall
precision + recall
,
where
precision =
true positives
true positives + false positives
, and
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recall =
true positives
true positives + false negatives
.
The range of the F-score [0, . . . , 1]. This score is typically used to evaluate classifier
quality.
The F-score for the data analyzed with SamSPECTRAL was the best, with a score of
0.97. FlowMeans also performed well with an F-score of 0.91. As was seen with the
visualization, FLAME failed to give reasonable clusters and had an F-score of 0.63.
In addition to accuracy, when an analysis is concerned, computational resources should
be considered. There were clear differences in wall clock time when running the algo-
rithms using five parallel processes for 10 data files. The flowMeans algorithm was the
fastest (1.5 h) followed by SamSPECTRAL (6h) and FLAME (40h).
When considering these three performance measures, it can be seen that SamSPEC-
TRAL performed the best for accuracy, but it is also slower than flowMeans. In an
actual analysis it would make sense to use a fast but not as accurate method for the
preprocessing stage of filtering out debris, and then using the more accurate method
for identifying the specific populations, as the clustering algorithms’ speed is depen-
dent on the amount of data that needs to be clustered. The FLAME based mixture
modeling was found to give biologically incorrect clusters and was very slow. The mix-
ture modeling results appear to greatly overfit the data. The method is shown to work
with simple datasets (Pyne et al., 2009), but according to our analysis, the method is
not suited for larger, high-noise datasets.
5.2.2 Multiple sample analysis
One of the aims of the FlowAnd library was to enable the analysis of large-scale ex-
periments with tens to hundreds of patients and experiment files. To demonstrate this
capability, we used data collected from 37 patients run with two different measurement
panels, resulting in 74 FCM files. The aim was to reanalyze data from Jalkanen et al.
(2011), where they identified a statistically significant difference in STAT3 expression
of the lymphocytes in dasatinib treated patients. The analysis pipeline was setup to
identify the lymphocyte population, calculate the median STAT3 values and perform
a Kruskall-Wallis test on these values.
For gating, flowMeans was used due to its high speed and good accuracy. We used
two rounds of clustering to make sure that all biologically relevant cell populations
were identified. The first round was run with a completely automated version of the
flowMeans algorithm, which calculates the number of clusters automatically as a part
of the algorithm. During the analysis, when the user labeled the cell populations and
found that the data had not been divided into a sufficient number of clusters, these
were labeled for a second round of clustering. This second round used a minimum
number of clusters as a parameter for the flowMeans algorithm and was always able to
identify enough clusters for the labeling of the lymphocyte population in all data files
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used. Running the whole analysis of 74 FCM files with 10 parallel processes took only
8.5 hours. The manual time required was only 20 minutes for labeling the clustered
data into their respective populations. The FLAME webservice through Gene Pattern
or its standalone version were not able to handle these amounts of data.
The Kruskall-Wallis test was run for the STAT3 values for lymphocytes in four different
patient groups: control (n = 7), diagnosis-phase patients (n = 10), patients after
imatinib treatment (n = 10) and patients after dasatinib treatment (n = 10). The
null hypothesis was that the populations had equal medians for STAT3 expression and
a p-value less than 0.05 was considered significant. As FlowAnd is a library in the
Anduril framework, performing statistical tests with data was straightforward and did
not require separate tools.
The analysis of large multidimensional FCM datasets requires tools like FlowAnd,
which are able to identify cell populations and perform relevant downstream analysis
automatically. Additionally, the FlowAnd framework ensures that the analysis is re-
producible and well documented. The tools are flexible to work with, and the analysis
can easily be modified to fit various types of FCM experiments.
5.3 Interpretation and integration of proteomics and tran-
scriptomics data (III)
In publication III, we analyzed quantitative MS/MS data to investigate the effects
of β-glucans on macrophages. β-glucans are a carbohydrate present in the cell wall
of fungi, and their role in host-specific recognition of these pathogens is of interest.
Various types of fungi are associated with various diseases in humans and animals, such
as respiratory allergies and skin diseases (Hasnain et al., 1985, Horner et al., 1991).
Pattern recognition receptors (PRRs) on immune cells are responsible for recognition
of pathogen-associated molecular patterns (PAMPs), which are molecules associated
with microbial pathogens or cell stress, and damage-associated molecular patterns
(DAMPs), which are molecules associated with cell components released when the cell
is damaged (Akira and Hemmi, 2003, Rubartelli and Lotze, 2007). As β-glucans are
present in the cell wall of fungi, they are potentially important PAMPs. It has been
shown that β-glucans activate dectin-1 and NLRP3 inflammasome, PPRs present on
macrophages, monocytes and dendroid cells (Brown et al., 2002, Taylor et al., 2007,
Martinon et al., 2002, 2009, Kankkunen et al., 2010), however the effects on cellular
signaling have not been characterized.
Macrophages were stimulated with either one of two β-glucans, Curdlan or GBY, or
a traditional stimulant, LPS, for comparison. The secreted proteins were analyzed
by quantitative proteomics. In addition to proteomics data, we also collected tran-
scriptomics data from the cells to investigate cellular processes related to β-glucan
stimulation.
For each stimulation, the secreted proteins were analyzed with 4-plex iTRAQ and LC-
MS/MS with two biological replicates. For the two experiments, we quantified 1,587
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proteins in the first replicate and 912 proteins in the second replicate, with an overlap
of 819 proteins. The β-glucans, both Curdlan and GBY, increased protein secretion
in comparison to LPS, both in the absolute amount of protein secreted and number of
proteins identified. Curdlan stimulated the secretion of 1,285 proteins and GBY 1,521
proteins, both with a fold change greater than two compared to the unstimulated
control. LPS only increased the stimulation of 29 proteins. In the set of proteins
stimulated by the two β-glucans, 1,194 were stimulated by both, showing that Curdlan
and GBY cause a similar β-glucan effect on macrophages.
To examine what could be the cause of protein secretion, the gene expression analy-
sis of the cells was also measured with the three different stimulations. Overall, we
found 1,683, 767 and 1,447 genes with over two-fold over- or underexpression in LPS-,
curdlan- and GBY-stimulations, respectively. The gene expression signatures of the
β-glucan-stimulated macrophages correlated highly, with a coefficient of determination
(r2) of 0.5.
Comparing individual genes and proteins from the list did not show high overlaps
between gene expression and protein secretion. For Curdlan, of the 1,285 proteins
stimulated, only 56 (4%) were also increased at transcriptional level, and a similar
value of 4% was found for GBY. As for LPS stimulation, there were only 29 proteins
with increased secretion and 1,683 genes enriched, of which 16 overlapped. The lack of
overlap in individual gene to protein, or transcription to translation pathways, shows
that increased protein secretion is not a result of a straightforward increase in protein
translation due to increased gene transcription. It was this type of data that were
specifically identified as being of interest.
Instead of looking at individual genes, more information can be revealed when examin-
ing the data from a higher level of abstraction, at annotated gene ontologies or KEGG
pathway assignments. Gene ontology enrichment was performed for both datasets,
and cellular localization for the majority of β-glucan induced proteins were identified
as intracellular and not plasma membrane or extracellular and secreted. SPIA analy-
sis identified the most perturbed KEGG pathways according to the iTRAQ data and
separately for the gene expression data.
As we were measuring secreted proteins, we used SignalP to identify which of the mea-
sured proteins were predicted to be secreted according to conventional protein secretion
pathways. Only around a quarter of the proteins with measured induction with GBY
or Curdlan were found to have a signal peptide in them, suggesting that other secre-
tion pathways would be involved. It was identified that the exosome pathways could
be relevant as another 20% of secreted proteins were found to be exosomal proteins
as identified by the ExoCarta database (Mathivanan et al., 2012). By enriching the
exosomal fraction of the β-glucan stimulated cells and analyzing it by Western blot-
ting against known exosomal marker proteins, it was confirmed that exosomal proteins
were being secreted. There were also many lysosomal proteins identified in the proteins
induced by β-glucan stimulation, and the KEGG pathway analysis identified the lyso-
some pathway as the major non-inflammatory enriched pathway. The data showed
that there was a large number of lysosomal enzymes being secreted after β-glucan
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stimulation, as well as proteins involved in lysosome enzyme transport from ER to the
lysosomes, suggesting that β-glucans activate an unconventional vesicle-mediated form
of protein secretion.
There were many immune system proteins found perturbed in the pathway analy-
sis, such as the DAMPs (damage-associated molecular pattern). The secretome data
showed clear upregulation of the DAMPs, but gene expression was not increased. Of
the identified DAMPs, only one was predicted by SignalP to be secreted by a classical
signal peptide mechanism and over half of the identified DAMPs were found in the
ExoCarta database, suggesting they would be secreted through exosomes.
β-glucans were also found to stimulate the secretion of proteins involved in leukocyte
migration and proteins which regulate actin cytoskeleton reorganization. Based on
SignalP-prediction and exosomal database status, migration proteins were suggested
to use both signal peptide mediated conventional secretion and vesicle-mediated non-
conventional mechanisms.
It was important to assess that the secreted proteins were not simply leaking due to
apoptosis. In fact, there were both pro- and anti-apoptotic proteins upregulated after
β-glucan stimulation. The gene expression of these proteins was not highly upregu-
lated, but when assaying for apoptosis with Western blotting for caspase-3 and IL-18,
the active forms of these proteins were not found, suggesting there was no apoptosis in
the cells. On the contrary, when apoptosis was induced by influenza A virus infection
(Rintahaka et al., 2008) in the presence and absence of curdlan, it was found that
curdlan had inhibited apoptosis in these cells, suggesting an anti-apoptotic effect.
Integrating information from experimental data and available knowledge from bio-
logical databases like GO, KEGG, ExoCarta and SignalP, it was possible to identify
possible new cellular mechanisms related to β-glucans.
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6 Conclusions and future prospects
The aims of this thesis were to develop and utilize computational methods for pro-
teomics data analysis at three stages: preprocessing, analysis and interpretation. The
particular task in data preprocessing was on validation of phospho-MS/MS data. For
this we developed an integrated data managing platform, phoMSVal, for validation of
identified peptides. Using phoMSVal on over 2,600 spectra, we were able to reduce
false positive identifications of phosphorylation sites of peptides.
PhoMSVal was developed at a stage when there were no sufficient tools for validat-
ing spectra, and manual validation consumed a large portion of time after complet-
ing experiments. Currently, there are tools available for a workflow analysis of mass
spectrometry data like TPP (Deutsch et al., 2010), SearchGUI (Vaudel et al., 2011),
Spectrum Mill (Agilent), MaxQuant (Cox and Mann, 2008) and others that have inte-
grated components for data analysis. Mass spectrometry based bioinformatics is still
an area where more work is needed, partly due to the steep learning curve involved
in understanding the technical aspects of mass spectrometry (Noble and MacCoss,
2012). Although there are popular tools available, this field of bioinformatics is likely
to expand in the coming years, especially due to the importance of quantitative phos-
phoproteomics as a tool for understanding and modeling cell signaling pathways.
Although flow cytometry is a routine method in clinical and basic research, there was
a paucity of tools for computational data analysis that would not require extensive
manual work. Software like FACSDiva, Cytobank and FLAME are suitable for manual,
small scale tasks, but they either require the use of additional software for downstream
analysis or their algorithms cannot handle large quantities of data. The FlowAnd
library developed in Publication II, resulted in a flexible set of tools that can be used
for data importing and analysis, including automated gating of cells. Three clustering
algorithms were implemented in FlowAnd, and additional tools can be easily added.
The recent development of single-cell mass spectrometry (Ornatsky et al., 2010, Bendall
et al., 2011, Nolan, 2011), it has become possible to measure up to 45 parameters
from a single cell. This type of data requires novel data analysis methods due to the
high dimensionality of the data (Qiu et al., 2011). These experiments will require
scalable data analysis methods, as such datasets are no longer possible to interpret
with traditional methods.
Data interpretation in the case of quantitative proteomics involves the use of sev-
eral computational methods. In Publication III, the secretome of β-glucan induced
macrophages was measured and characterized. By integrating proteomics data with
measurements from gene expression microarrays, it was possible to identify which se-
creted proteins were induced due to increases in gene expression, and which proteins
were secreted by other means. With the use of information from biological databases
such as GO, KEGG, and ExoCarta and prediction software like SignalP, it was possible
to deduce that a large part of protein secretion due to β-glucan stimulation happened
though non-conventional vesicle-mediated pathways rather than traditional signal pep-
tide mechanisms.
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With the advancement of next-generation sequencing, human exomes are being se-
quenced and variations in protein coding areas will soon be found in a routine manner
(Morozova and Marra, 2008). Linking exome data to proteomics data is not straight-
forward, as proteins come in various isoforms and mutations in DNA can affect gene
expression, gene splicing, and protein structure and stability. Methods for proteomics
analysis will also continue to develop, allowing for even more resolution in the identifi-
cation and measurement of the proteome. In addition to requiring tools for integration,
these genomic, transcriptomic and proteomic datasets are becoming larger with each
step of technology. Data management of these various high-definition datasets will be
an interesting challenge of the future. The success of this field of research will provide
great advancements for biomedical science.
Machine learning methods have a significant role in the analysis of biological data
(Tarca et al., 2007), which was demonstrated in this thesis. Random forests seem to
be the most rapidly growing method in biomedical research, and ANNs have been quite
widely used and their use may be decreasing (Jensen and Bateman, 2011). Clustering
algorithms for analysis of flow cytometry data can still be improved, for enabling even
more robust and reliable results in less time.
This study demonstrated that the desire to study complex biological diseases with high-
throughput proteomics methods requires advanced bioinformatics tools. The methods
developed and applied were able to improve MS data quality, enabled the analysis
of large patient datasets with FCM and showed the integration of various types of
datasets with database information can significantly improve the generation of biolog-
ical hypotheses and also help in answering these questions.
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